Former Deputy Director of Diagnostics, Bill and Melinda Gates Foundation,...
Dr. Giachetti’s extensive experience managing complex diagnostics programs make her a valuable…
Read Blog Post
New Manufacturing and Import License Expands Batch Certification Services
ProPharma Group announced that its wholly-owned subsidiary ProPharma Group The Netherlands B.V.,…
Read Blog Post
ProPharma Group and The Planet Group Announce Agreement to Merge
ProPharma Group and The Planet Group have reached a definitive agreement to…
Read Blog Post
ProPharma Group Announces the Acquisition of Diamond Pharma Services
ProPharma Group, a portfolio company of Odyssey Investment Partners, announces the acquisition…
Read Blog Post
Mydecine Innovations Group Engages ProPharma Group to Proceed with FDA...
Leading FDA consultancy firm to advise on drug development and clinical trial…
Read Blog Post
Odyssey Investment Partners To Acquire ProPharma Group
Odyssey Investment Partners (“Odyssey”) announced today that it has entered into an…
Read Blog Post
Linden Agrees to Sell ProPharma Group to Odyssey Investment Partners
Linden Capital Partners (“Linden”), a Chicago-based private equity firm focused exclusively on…
Read Blog Post
ProPharma Group Announces Acquisition of Southwood Research
Southwood Research is a leading provider of pre-approval regulatory science services to…
Read Blog PostYour Business has Complex Challenges. ProPharma Group has Exceptional Solutions.
We partner with pharmaceutical, biotechnology, and medical device clients to tackle complex challenges. Contact us to learn how our experienced team can help ensure regulatory and development success throughout the product lifecycle.
Interested in gaining an industry edge? Let us help you stay up to date.
Sign up to receive updates and industry insights